How many patents does
Infectious Disease Research Institute have?
patents
360
families
31
granted
75
applications
285
US
76
EP
50
WO
31
CN
26
JP
22
KR
5
RoW
150
Buy the report
The report contains ten-year analysis with the following sections
- patent filing analysis
- worldwide filing analysis
- patent family analysis
- application analysis
- granted analysis
- classification analysis
- citation analysis
contact us for pricing
- VAT will apply to UK companies
- EU companies must supply their VAT number
Check out our sample pages |
Find companies to compare
Many companies now available
companies
12,000+
patents
42 million
patent families
23 million
Search to find companies of interest
read summary of their published patent
the following tables are just extracts from the report
the company report contains more information
Infectious Disease Research Institute
Top ten assignees appearing on patents
2009 - 2018
| glaxosmithkline biologicals | 52 |
| inbios international | 4 |
| paxvax | 4 |
| summit corporation | 2 |
| hawaii biotech | 1 |
| summit corp. | 1 |
Infectious Disease Research Institute
The top ten patent families are
|
Title of patent family (most common patent title) |
Family members |
Filing year |
|---|---|---|
| vaccine composition containing synthetic adjuvant | 75 | 2006 |
| novel method for preventing or treating m tuberculosis infection | 57 | 2005 |
| synthetic glucopyranosyl lipid adjuvants | 43 | 2009 |
| immunogenic compositions comprising mycobacterium tuberculosis polypeptides and fusions … 🛈 | 23 | 2007 |
| fusion proteins and their use in the diagnosis and treatment of leishmaniasis | 16 | 2008 |
| anti-xdr-tb agent, anti-mdr-tb agent, and combined anti-tuberculous agent | 13 | 2008 |
| recombinant polyprotein vaccines for the treatment and diagnosis of leishmaniasis | 13 | 2008 |
| single vial vaccine formulations | 13 | 2013 |
| vaccine composition containing synthetic adjuvant | 12 | 2008 |
| compositions and methods for treating an active mycobacterium tuberculosis infection | 11 | 2012 |